Dr Christopher Rowe is a Consultant Endocrinologist at John Hunter Hospital in Newcastle. His group’s research addresses the management of acute glycaemic instability in the peripartum period, particularly following antenatal glucocorticoids. The Newcastle group has developed and validated the Pregnancy-IVI, a midwife-led, obstetrician-supervised intravenous insulin protocol to achieve safe, at-target glycaemia for unstable inpatients. Outside of pregnancy research, his doctoral studies examined neurotrophins in nodular thyroid disease, and he has published on the management of thyroid nodules and thyroid cancer in pregnancy.